Search - tctmd.com

Displaying 201 - 220 of 562

Sort: Relevancy | Date

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Daily News

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

L.A. McKeown

June 04, 2018

News Conference News EuroPCR 2018

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Yael L. Maxwell

May 30, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Daily News

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

L.A. McKeown

April 19, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

Presentation ACC 2018

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

Presenter: Hyeon-Cheol Gwon

March 12, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Shelley Wood

March 11, 2018

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Shelley Wood

March 11, 2018

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Despite Increasing Access to Invasive Cardiac Care, Rural Patients Still at a Disadvantage

Leah Lawrence

February 09, 2018

News Daily News

Could NOACs Have a Role for Secondary Prevention After STEMI?

Todd Neale

February 08, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Caitlin E. Cox

January 11, 2018

News Daily News

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Yael L. Maxwell

January 03, 2018

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

Advertisement

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

6-Month versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE)

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Despite Increasing Access to Invasive Cardiac Care, Rural Patients Still at a Disadvantage

Could NOACs Have a Role for Secondary Prevention After STEMI?

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content